Thomas Jefferson University is on the forefront of research lab science and healthcare development. Although the university is based in Philadelphia, Thomas Jefferson administrators and research lab scientists envision the school breaking out into the global science research market. Dr. Stephen K. Klasko, president of Thomas Jefferson University, has an innovative plan to unite Thomas Jefferson University, Thomas Jefferson University Hospitals and the institution’s 800 physicians under a single entity.
The University of Pennsylvania is currently in the planning stages of constructing a new research campus along the Schuylkill River. The South Bank of the Schuylkill, pronounced ‘SKOO-kəl,’ is a vital component of the University of Pennsylvania’s campus development vision. The Penn Connects 2.0 strategy has added 3 million square feet of space to new UPenn research campuses since 2006.
Research funding at the University of Pennsylvania will increase in 2014 thanks to the grants from the NIH and several other organizations.
Patrick Moore, M.D., M.P.H., director of the Molecular Virology Program at the University of Pittsburgh Cancer Institute (UPCI), will receive more than a $2 million new grant from the NIH to continue research into the human cancer virus that causes most Merkel cell carcinomas, a rare but deadly skin cancer. This new grant will fund the research through March 2019.
UPenn is a top research marketplace with significant funding from federal and private sources. In addtion to the main campus, UPENN is developing property on the Schulkill River to expand its research facilities and programs.
This year the annual BioResearch Product Faire™ Event at Thomas Jefferson University will be held on campus in close proximity to researchers, research labs, and department adminstrators. This marks a change over the past few years when the show was held off campus at a local hotel. This event is open to Philadelphia area life science professionals interested in seeing the newest lab technologies available. This year the event will be held at the Bluemle Life Science Building where as many as 20 companies will be present to share their newest technologies with the Thomas Jefferson research community.
At the University of Pennsylvania, three faculty members have been awarded Sloan Fellowships. For over 50 years the Alfred P. Sloan Foundation has identified and recognized young scientists with significant leadership potential. We'd like to invite our readers in joining us to recognize the already significant contributions and long term career potential of the following UPENN scientists as reported by Evan Lerner today at UPENN:
Researchers at the University of Pittsburgh recently received $10.4 million in life science funding from the NIH at the end of July this year. The administering center for the award at the NIH was the National Center for Advancing Translational Sciences, and the life science funding will be given to the University of Pittsburgh Clinical and Translational Science Institute. More information on the Clinical and Translational Science Institute is available on the NIH RePORTER project abstract:
Lab suppliers working to market life science solutions in Philadelphia will find a market rich with life science funding at Thomas Jefferson University. According to recent NIH and NSF funding statistics, the NIH awarded Thomas Jefferson University $49.7 million in research funding in 2012. In addition to receiving NIH research funding, Thomas Jefferson University received $318,984 in NSF life science funding for life science projects alone.